查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715873

周邊血管設備市場：按產品類型、技術類型、材料類型、適應症、患者類型、最終用戶 - 2025-2030 年全球預測

Peripheral Vascular Devices Market by Product, Technology Type, Material Type, Indication, Patient Types, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年周邊血管設備市場價值將達到139億美元，2024年將成長至146.6億美元，複合年成長率為5.95%，到2030年將達到208.5億美元。

主要市場統計數據
基準年2023年 139億美元
預計2024年 146.6億美元
預測年份 2030 208.5億美元
複合年成長率（%） 5.95%

周邊血管裝置市場是現代醫療保健的一個重要領域，在慢性病增多和微創治療需求不斷成長的壓力下，該市場不斷發展。在這個市場中，技術創新不僅可以改善患者的治療效果，還可以提高醫療保健提供者的業務效率並節省成本。如今，技術進步的快速步伐，加上臨床醫生和患者的動態需求，使得周邊血管裝置成為關鍵的關注領域。

從支架到移植物，這些設備體現了卓越的工程技術與醫療需求的交匯，為精確解決複雜的血管疾病創造了機會。不斷發展的醫療保健格局的特點是監管環境的變化、對血管疾病的科學理解的加深以及向微創治療方法的堅定轉變。隨著數位健康和​​先進製造技術融入該領域，周邊血管設備對於全球心血管護理的成功發揮著更為重要的作用。

摘要提供了全面的概述，重點關注市場現狀以及轉型趨勢、細分洞察、區域動態、主要企業活動和未來成長的可行建議。本書將幫助決策者、投資者和醫療保健專業人士在快速變化的環境中掌握這個市場潛力的細微差別。

改變周邊血管設備市場

在過去的十年中，周邊血管設備市場經歷了一系列由技術、監管和人口因素推動的變革時期。最大的變化之一是從傳統的開放性手術轉向微創手術。這些治療方法不僅縮短了恢復時間，而且還最大限度地降低了與更具侵入性的干涉相關的風險，提高了患者滿意度並擴大了門診治療選擇的範圍。

技術進步透過引入具有更高控制力和精度的創新設備再形成了市場。這些發展使工程師能夠設計出更靈活和耐用的支架和導管導引線，以及利用能夠對身體生理變化做出反應的智慧材料。製造商現在專注於將數據分析和即時影像處理功能融入設備設計中，這種轉變將繼續提高效率並改善安全結果。

此外，市場更加重視個人化的醫療保健解決方案。針對特定病患的醫療設備是先進影像處理方式和精密工程的成果，現在比以往任何時候都更可行。監管改革有助於縮短上市時間，同時確保這些設備符合嚴格的安全和性能標準。隨著傳統產品的逐步淘汰和對創新個人化治療方法的需求，周邊血管應用精準醫療的趨勢是不可避免的，也是值得歡迎的。

這些市場動態受到技術力融合和不斷發展的臨床實踐的影響，從而改善治療結果並增強全球市場的競爭力。降低手術風險、簡化製造流程以及改善臨床結果的結合為該領域的持續成長和投資鋪平了道路。

周邊血管設備關鍵細分市場洞察

對周邊血管設備市場進行徹底的分析可以發現其結構高度分散，從而可以更深入地了解各個層面的商業機會。市場根據產品類型、技術、材料、適應症、患者概況和最終用戶進行細分。就產品領域而言，這些包括球囊擴張裝置、導管、移植物、導管導引線、下腔靜脈濾器、導引器、斑塊改造裝置、支架和血管閉合裝置。值得注意的是，導管類別進一步細分為長周邊靜脈導管、中線導管和短周邊靜脈導管，突顯了不同臨床環境中治療的細微差別。同樣，移植物又細分為生物移植物、ePTFE移植物和聚酯移植物，而支架又進一步細分為球囊擴張型支架和自動擴張型支架。

就技術類型而言，市場上微創手術和開放性手術各佔一半。微創手術包括血管成形術和支架置入術，由於其可降低手術風險並加快患者恢復時間，因此佔據了大多數干預措施。相較之下，開放性手術（包括搭橋手術和動脈內膜切除術）在複雜情況下必不可少，因為在這些情況下，侵入性較小的方法不夠有效。

根據材料成分分析，市場大致分為金屬和非金屬。金屬裝置通常採用鈷鉻合金、鎳鈦合金和不銹鋼等材料，因為它們堅固且能夠適應複雜的血管解剖結構，而非金屬解決方案則利用強調靈活性和與身體組織的兼容性的聚合物和矽膠材料。這種細分顯示了材料科學的創新如何與設備的功能性和耐用性相關聯。

此外，從適應症來看，可分為功能性周邊血管疾病和閉塞性周邊血管疾病兩大類。功能性疾病包括慢性靜脈功能不全、雷諾氏症和靜脈曲張等疾病，需要確保持續、舒適的血管支持的設備。另一方面，動脈粥狀硬化、血栓性血栓形成、頸動脈疾病、深層靜脈栓塞症和淋巴水腫等阻塞性疾病需要更積極的干涉策略，因為設備的功效直接影響患者的預後。

患者屬性將進一步細分，分為成人/老年族群和兒科族群。前者是急性和慢性疾病，其中設備在長期健康管理中發揮關鍵作用。兒科患者，無論是後天或先天性疾病，都需要專門的設備來應對年輕患者獨特的生理挑戰。最後，按最終用戶進行市場細分錶明，門診手術中心、診所和醫院等分銷管道各自產生獨特的需求模式，影響整個臨床頻譜的設備設計和使用。

這些定義複雜的細分層提供了寶貴的見解，使相關人員能夠找到新的機會、客製化產品創新並制定有針對性的策略以實現最佳的市場滲透。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 周邊血管疾病盛行率不斷上升
      • 人們對微創治療方案的興趣日益濃厚
    • 限制因素
      • 與高成本和產品召回相關的周邊血管裝置
    • 機會
      • 周邊血管裝置的進展
      • 政府對醫療基礎設施的支持與投資
    • 任務
      • 醫療設備核准和處置的嚴格規定
  • 市場區隔分析
    • 產品：越來越多使用導管進行慢性治療
    • 技術類型：為了滿足患者更快康復和更少創傷的需求，微創手術正在被迅速採用。
    • 材料類型：快速採用具有優異生物相容性和降低血栓形成的非金屬設備
    • 適應症：發展周邊血管裝置用於治療需要生命相關干預的阻塞性周邊血管疾病（OPVD）
    • 患者類型：周邊血管裝置在成年患者的重要應用
    • 最終用戶：擴大整個醫院環境中周邊血管設備的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 周邊血管設備市場（依產品）

  • 氣球充氣裝置
  • 導管
    • 長周邊靜脈導管
    • 中線導管
    • 短周邊靜脈導管
  • 移植
    • 生物移植
    • ePTFE 移植物
    • 聚酯接枝
  • 導管導引線
  • 下腔靜脈濾器
  • 推薦人
  • 斑塊修飾裝置
  • 支架
    • 球囊擴張型支架
    • 自動擴張型支架
  • 血管閉合裝置

7. 周邊血管設備市場（依技術類型）

  • 微創手術
    • 血管成形術
    • 支架置入術
  • 開放性手術
    • 心臟繞道手術
    • 切除術

8. 周邊血管裝置市場（依材料類型）

  • 金屬設備
    • 鈷鉻合金
    • 鎳鈦合金
    • 不銹鋼
  • 非金屬設備
    • 聚合物
    • 矽膠

第9章周邊血管設備市場（按適應症）

  • 功能性周邊血管疾病
    • 慢性靜脈功能不全
    • 雷諾氏症
    • 靜脈曲張
  • 閉塞性周邊血管疾病
    • 動脈硬化
    • 血栓閉塞性脈管炎
    • 頸動脈疾病
    • 深層靜脈栓塞症
    • 淋巴水腫

第 10 章周邊血管設備市場（依病患類型）

  • 成年人和老年人
    • 急性病
    • 慢性病
  • 小兒科
    • 後天疾病
    • 先天性疾病

第 11 章 周邊血管設備市場（依最終用戶）

  • 門診手術中心
  • 診所
  • 醫院

12. 美洲周邊血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

13. 亞太地區周邊血管設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

14. 歐洲、中東和非洲周邊血管設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • AMECATH
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • ASAHI INTECC CO., LTD
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Cordis
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Kimal PLC
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Sahajanand Medical Technologies Limited
  • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • Siemens Healthineers AG
  • Summa Therapeutics, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market was valued at USD 13.90 billion in 2023 and is projected to grow to USD 14.66 billion in 2024, with a CAGR of 5.95%, reaching USD 20.85 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 13.90 billion
Estimated Year [2024] USD 14.66 billion
Forecast Year [2030] USD 20.85 billion
CAGR (%) 5.95%

The peripheral vascular devices market represents a critical segment in modern healthcare that continues to evolve under the pressure of rising chronic diseases and the increasing demand for minimally invasive therapies. In this market, innovation drives not only improved patient outcomes but also operational efficiencies and cost reductions for healthcare providers. Today, the rapid pace of technological advancement combined with the dynamic needs of clinicians and patients has positioned peripheral vascular devices as a pivotal area of focus.

These devices, which range from stents to grafts, embody the intersection of engineering excellence and medical needs, creating opportunities to address complex vascular conditions with enhanced precision. The evolving healthcare landscape is marked by shifting regulatory standards, deeper scientific understanding of vascular conditions, and an unwavering shift towards less invasive treatment options. As digital health and advanced manufacturing techniques integrate into this space, the role of peripheral vascular devices becomes even more central to the success of cardiovascular interventions around the globe.

This summary serves to provide a comprehensive overview that highlights not only the market's current state but also the transformative trends, segmentation insights, regional dynamics, leading company activities, and actionable recommendations for future growth. The narrative that follows will help decision-makers, investors, and healthcare experts grasp the nuances of this market's potential in a rapidly changing environment.

Transformative Shifts in the Peripheral Vascular Devices Landscape

Over the past decade, the peripheral vascular devices market has undergone a series of transformative shifts driven by technology, regulation, and demographics. One of the most significant changes has been the transition from traditional open surgeries to minimally invasive procedures. These procedures not only reduce recovery times but also minimize the risks associated with more invasive interventions, thereby improving patient satisfaction and widening the scope for outpatient treatments.

Technological advancements have reshaped the market by introducing innovative devices that offer enhanced control and precision. These developments have, for example, enabled engineers to design stents and guidewires with improved flexibility and durability while also leveraging smart materials that can respond to physiological changes within the body. Manufacturers now focus on integrating data analytics and real-time imaging capabilities into device design, a shift that is continuously driving efficiency and improving safety outcomes.

Additionally, the market has seen an increased emphasis on personalized healthcare solutions. Patient-specific devices, created as a result of advanced imaging modalities and precision engineering, are now more attainable than ever. Regulatory reforms have facilitated a faster time-to-market while ensuring that these devices adhere to stringent safety and performance standards. With the brown field of legacy products making way for innovative, patient-tailored therapies, the trend towards precision medicine in peripheral vascular applications is both inevitable and welcome.

These market dynamics, influenced by the convergence of technological prowess and evolving clinical practices, have led not only to enhanced therapeutic outcomes but also to a more competitive global marketplace. The combination of reduced procedural risks, streamlined manufacturing processes, and improved clinical results is paving the way for sustained growth and investment in the sector.

Key Segmentation Insights in Peripheral Vascular Devices

A thorough appraisal of the peripheral vascular devices market reveals a highly segmented structure that facilitates a deeper understanding of the opportunities at various levels. The market is dissected based on product type, technology, material, indication, patient profile, and end-user. Regarding product segmentation, the domain encompasses balloon inflation devices, catheters, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure devices. Distinctively, the catheter category experiences further granularity by distinguishing long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters, highlighting the variations in treatment nuances across different clinical settings. Similarly, grafts subdivide into biological grafts, ePTFE grafts, and polyester grafts, while stents further divide into balloon-expandable stents and self-expanding stents.

When considering technology type, the market equally splits between minimally invasive surgeries and open surgeries. Minimally invasive procedures are further examined under the banners of angioplasty and stenting, which collectively represent a significant portion of the interventions due to their reduced operative risk and quicker patient recovery times. In contrast, open surgery, categorized into bypass surgery and endarterectomy, remains indispensable for complex scenarios where less invasive approaches may not suffice.

Material composition analysis shows that the market is bracketed by metal and non-metal devices. Metal devices often feature substances like cobalt chromium, nitinol, and stainless steel because of their robustness and an ability to conform to intricate vascular structures, while non-metal solutions utilize polymer and silicone materials that emphasize flexibility and compatibility with bodily tissues. Such segmentation demonstrates how material science innovations translate into device functionality and durability.

Furthermore, an examination of indications reveals two broad categories: functional and occlusive peripheral vascular diseases. Functional conditions, which include ailments such as chronic venous insufficiency, Raynaud's disease, and varicose veins, demand devices that ensure consistent and comfortable vascular support. On the other hand, occlusive conditions like atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema require a more aggressive intervention strategy where device efficacy can directly influence patient prognosis.

Patient demographics further enrich segmentation with classifications into adult & geriatric and pediatric populations. The former is signified by acute and chronic conditions where devices play a crucial role in managing long-term health. Pediatric cases, whether stemming from acquired or congenital conditions, demand specialized device considerations given the unique physiological challenges of younger patients. Finally, the market segmentation by end-user demonstrates that the distribution channels include ambulatory surgical centers, clinics, and hospitals, each creating unique demand patterns and influencing the design and usage of devices across the spectrum of clinical practice.

These intricately defined segmentation layers provide valuable insights that enable stakeholders to pinpoint emerging opportunities, tailor product innovations, and devise targeted strategies for optimal market penetration.

Based on Product, market is studied across Balloon Inflation Devices, Catheters, Grafts, Guidewires, Inferior Vena Cava Filters, Introducers, Plaque Modification Devices, Stents, and Vascular Closure Devices. The Catheters is further studied across Long Peripheral Intravenous Catheters, Midline Catheters, and Short Peripheral Intravenous Catheter. The Grafts is further studied across Biological Grafts, ePTFE Grafts, and Polyester Grafts. The Stents is further studied across Balloon-Expandable Stents and Self-Expanding Stents.

Based on Technology Type, market is studied across Minimally Invasive Surgeries and Open Surgery. The Minimally Invasive Surgeries is further studied across Angioplasty and Stenting. The Open Surgery is further studied across Bypass Surgery and Endarterectomy.

Based on Material Type, market is studied across Metal Devices and Non-Metal Devices. The Metal Devices is further studied across Cobalt Chromium, Nitinol, and Stainless Steel. The Non-Metal Devices is further studied across Polymer and Silicone.

Based on Indication, market is studied across Functional Peripheral Vascular Disease and Occlusive Peripheral Vascular Disease. The Functional Peripheral Vascular Disease is further studied across Chronic Venous Insufficiency, Raynaud's Disease, and Varicose Veins. The Occlusive Peripheral Vascular Disease is further studied across Atherosclerosis, Buerger's Disease, Carotid Artery Disease, Deep Vein Thrombosis, and Lymphedema.

Based on Patient Types, market is studied across Adult & Geriatric and Pediatric. The Adult & Geriatric is further studied across Acute Conditions and Chronic Conditions. The Pediatric is further studied across Acquired Conditions and Congenital Conditions.

Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Regional Insights Shaping Market Opportunities

The geographic landscape of the peripheral vascular devices market is characterized by diverse regional trends that mirror distinct healthcare infrastructures and economic conditions. In the Americas, robust healthcare expenditure combined with advanced technological adoption drives market growth, where the integration of advanced devices in routine clinical practice is routinely observed. The region benefits from established regulatory frameworks that support innovation and create a conducive environment for research and development.

In Europe, the Middle East & Africa, healthcare systems are equally attuned to the benefits of state-of-the-art vascular interventions. This region experiences a blend of mature markets in Western Europe, emerging markets in Africa, and dynamic growth pockets in the Middle East. Variations in healthcare policies and reimbursement scenarios have resulted in a landscape where strategic partnerships and collaborations are vital to drive device adoption. Innovations in device manufacturing, particularly in terms of miniaturization and improved material properties, are notably well-received, further fostering market expansion in these areas.

Asia-Pacific stands at the forefront of market dynamism, driven by rapid urbanization, increasing healthcare awareness, and a surge in government initiatives aimed at improving healthcare infrastructure. The region's large population base coupled with rising disposable incomes ensures a significant demand for cutting-edge peripheral vascular devices. The market in Asia-Pacific is marked by an accelerating shift towards minimally invasive procedures as state-of-the-art surgical techniques become the norm in leading hospitals and urban clinics. Collectively, these regional insights underscore the importance of tailored strategies that take into account the unique economic and regulatory conditions inherent to each market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Leading the Peripheral Vascular Devices Sector

A closer examination of the competitive landscape reveals several key players that command significant influence over the peripheral vascular devices market. Market pioneers such as Abbott Laboratories and AMECATH have established robust portfolios that underscore their commitment to innovative solutions. Companies like AngioDynamics, Inc. and Argon Medical Devices, Inc. are known for their emphasis on research and development, ensuring that their products continuously integrate the latest technological advancements.

American industry leaders such as ASAHI INTECC CO., LTD demonstrate a high level of precision in device engineering, while firms like B. Braun SE and Baxter International Inc. continue to build on longstanding legacies of reliability and performance. Traditional industry stalwarts, including Becton, Dickinson and Company and BIOTRONIK SE & Co. KG, leverage a history of clinical excellence to bolster their market positions. Meanwhile, companies such as Boston Scientific Corporation and Cardinal Health, Inc. deliver comprehensive solutions that holistically address vascular challenges.

Cook Group Incorporated and Cordis further contribute to a competitive market environment with their innovative technology platforms that are reaping remarkable clinical benefits. Esaote S.p.A. and FUJIFILM Holdings Corporation have also made significant advances, integrating digital diagnostic capabilities with interventional device technologies. Industry leaders like GE HealthCare and Kimal PLC remain at the forefront of research and design, while Koninklijke Philips N.V. and Lepu Medical Technology (Beijing) Co., Ltd. continue to push the envelope in imaging and device synergy. Medtronic PLC and Merit Medical Systems, Inc. are prominent examples of companies that have built deep, diversified portfolios to meet a wide range of clinical needs.

Furthermore, the competitive landscape is buoyed by the contributions of Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, and Shockwave Medical, Inc. by Johnson & Johnson Services, Inc. Their efforts in combining engineering precision with clinical insight underscore the sector's focus on outcome-based solutions. Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc. round out a market populated by the most capable and innovative entities. The cumulative effect of this competitive environment is a continuous push for quality, cost-effectiveness, and technological advancement across the entire market.

The report delves into recent significant developments in the Peripheral Vascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMECATH, AngioDynamics, Inc., Argon Medical Devices, Inc., ASAHI INTECC CO., LTD, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Cordis, Esaote S.p.A., FUJIFILM Holdings Corporation, GE HealthCare, Kimal PLC, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, Shockwave Medical, Inc. by Johnson & Johnson Services, Inc., Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Industry Leaders

Decision-makers in the peripheral vascular devices market should capitalize on existing opportunities while preparing strategically for future challenges. One of the foremost recommendations is to invest heavily in research and development to continue driving innovative breakthroughs, particularly in the areas of minimally invasive surgery and personalized device design. It is vital to integrate advanced materials and incorporate digital health technologies that can provide real-time data to inform procedural improvements. Fostering partnerships between academia, clinical research centers, and manufacturers can help streamline the adoption of cutting-edge technologies.

Leaders should also consider diversifying product portfolios to include both metal and non-metal device options, ensuring that the range of products stays relevant across diverse patient profiles and complex vascular conditions. Moreover, adopting a segmentation-focused approach can serve companies well by allowing for precise targeting of treatments based on patient type and disease indication. By closely monitoring market segmentation trends and consumer behavior, companies can adjust their strategies to better cater to the distinct needs of adult, geriatric, and pediatric patient groups.

Expanding geographic footprint remains an essential tactic as well. Firms should leverage emerging markets in Asia-Pacific and regions with robust growth potential such as parts of Europe and the Middle East & Africa. This geographic diversification not only mitigates risk but also exposes companies to a wider array of opportunities, thereby ensuring sustained revenue growth.

Furthermore, industry leaders are encouraged to focus on operational excellence by optimizing supply chains and reinforcing quality assurance protocols. In an era where both regulatory demands and patient expectations are intensifying, aligning internal processes with global standards is paramount. Companies must balance innovation with precision in execution to ensure that high-quality products are accessible, economically feasible, and clinically effective.

Finally, proactive engagement with regulators and policy makers can help shape a favorable operating environment that encourages innovation while safeguarding patient health. Such collaboration is essential for accelerating device approvals and facilitating smoother market entry processes for next-generation products.

Conclusion: The Road Ahead in Peripheral Vascular Devices

In summary, the peripheral vascular devices market is poised for a new era marked by technological innovation, refined segmentation strategies, and expansive regional growth. The shift towards minimally invasive procedures and precision medicine has fundamentally redefined therapeutic strategies, ensuring that patient outcomes are continually improved. This evolution is supported by a wide array of product offerings, differentiated by material, indication, technology, and patient type, which together create a versatile and resilient market ecosystem.

The competitive landscape is vibrant, driven by leading companies that are steadfast in their commitment to clinical excellence and innovation. Such players continually refine their strategies and portfolios in response to emerging trends, thereby fostering a climate of healthy competition and sustainable growth. By aligning research, investment, and operational practices, the industry is well-prepared to address the evolving challenges of healthcare delivery on a global scale.

Looking forward, a collaborative approach that bridges clinical expertise, regulatory alignment, and technological advancement will be critical to unlocking the full potential of the peripheral vascular devices market. As the industry navigates an increasingly complex and competitive landscape, the convergence of these factors will define the future of vascular treatment modalities and drive long-term market sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The increasing prevalence of peripheral vascular diseases
      • 5.1.1.2. Rising preference for minimally invasive treatment options
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and product recalls associated peripheral vascular devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancement in the peripheral vascular devices
      • 5.1.3.2. Governmental support and investment in healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for approval and disposal of medical devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating usage of the catheters for prolonged therapy administration
    • 5.2.2. Technology Type: Rapid adoption of minimally invasive procedures fueled by patient demand for quicker recoveries and less traumatic experiences
    • 5.2.3. Material Type: Burgeoning utilization of non-metal devices providing superior biocompatibility and reduced thrombus formation
    • 5.2.4. Indication: Evolving usage of peripheral vascular devices for occlusive peripheral vascular disease (OPVD) driven by critical, life-preserving interventions
    • 5.2.5. Patient Types: Significant application of peripheral vascular devices the in adult patients
    • 5.2.6. End-User: Expanding applications of peripheral-vascular-devices across hospitals settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peripheral Vascular Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Inflation Devices
  • 6.3. Catheters
    • 6.3.1. Long Peripheral Intravenous Catheters
    • 6.3.2. Midline Catheters
    • 6.3.3. Short Peripheral Intravenous Catheter
  • 6.4. Grafts
    • 6.4.1. Biological Grafts
    • 6.4.2. ePTFE Grafts
    • 6.4.3. Polyester Grafts
  • 6.5. Guidewires
  • 6.6. Inferior Vena Cava Filters
  • 6.7. Introducers
  • 6.8. Plaque Modification Devices
  • 6.9. Stents
    • 6.9.1. Balloon-Expandable Stents
    • 6.9.2. Self-Expanding Stents
  • 6.10. Vascular Closure Devices

7. Peripheral Vascular Devices Market, by Technology Type

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgeries
    • 7.2.1. Angioplasty
    • 7.2.2. Stenting
  • 7.3. Open Surgery
    • 7.3.1. Bypass Surgery
    • 7.3.2. Endarterectomy

8. Peripheral Vascular Devices Market, by Material Type

  • 8.1. Introduction
  • 8.2. Metal Devices
    • 8.2.1. Cobalt Chromium
    • 8.2.2. Nitinol
    • 8.2.3. Stainless Steel
  • 8.3. Non-Metal Devices
    • 8.3.1. Polymer
    • 8.3.2. Silicone

9. Peripheral Vascular Devices Market, by Indication

  • 9.1. Introduction
  • 9.2. Functional Peripheral Vascular Disease
    • 9.2.1. Chronic Venous Insufficiency
    • 9.2.2. Raynaud's Disease
    • 9.2.3. Varicose Veins
  • 9.3. Occlusive Peripheral Vascular Disease
    • 9.3.1. Atherosclerosis
    • 9.3.2. Buerger's Disease
    • 9.3.3. Carotid Artery Disease
    • 9.3.4. Deep Vein Thrombosis
    • 9.3.5. Lymphedema

10. Peripheral Vascular Devices Market, by Patient Types

  • 10.1. Introduction
  • 10.2. Adult & Geriatric
    • 10.2.1. Acute Conditions
    • 10.2.2. Chronic Conditions
  • 10.3. Pediatric
    • 10.3.1. Acquired Conditions
    • 10.3.2. Congenital Conditions

11. Peripheral Vascular Devices Market, by End-User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Americas Peripheral Vascular Devices Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Peripheral Vascular Devices Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Peripheral Vascular Devices Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. AngioDynamics launches RECOVER-AV clinical trial to expand AlphaVac F1885 System usage in Europe
    • 15.3.2. Shockwave Medical's advanced catheter aims to redefine treatment landscape for complex peripheral artery disease
    • 15.3.3. Medtronic pioneers innovation in aortic procedures with the launch of Steerant aortic guidewire for endovascular aneurysm repair (EVAR) and thoracic EVAR (TEVAR)
    • 15.3.4. Philips unveils the Duo Venous Stent System revolutionizing treatment for venous outflow obstructions
    • 15.3.5. Abbott's revolutionary Esprit BTK dissolving stent sets a new standard in peripheral artery disease management
    • 15.3.6. AngioDynamics' AlphaVac F18 85 system gains FDA clearance, establishing a new standard in pulmonary embolism treatment strategies
    • 15.3.7. Strategic alliance between Zylox-Tonbridge and Avinger expands innovative OCT solutions in vascular interventions
    • 15.3.8. BD launches AGILITY study to assess innovative covered stent, aiming to expand peripheral arterial disease (PAD) treatment options worldwide
    • 15.3.9. Summa Therapeutics' Finesse catheter revolutionizes below-the-knee (BTK) angioplasty with innovative, multifunctional design
  • 15.4. Strategy Analysis & Recommendation
    • 15.4.1. Abbott Laboratories
    • 15.4.2. Merit Medical Systems, Inc.
    • 15.4.3. Boston Scientific Corporation
    • 15.4.4. Medtronic PLC

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AMECATH
  • 3. AngioDynamics, Inc.
  • 4. Argon Medical Devices, Inc.
  • 5. ASAHI INTECC CO., LTD
  • 6. B. Braun SE
  • 7. Baxter International Inc.
  • 8. Becton, Dickinson and Company
  • 9. BIOTRONIK SE & Co. KG
  • 10. Boston Scientific Corporation
  • 11. Cardinal Health, Inc.
  • 12. Cook Group Incorporated
  • 13. Cordis
  • 14. Esaote S.p.A.
  • 15. FUJIFILM Holdings Corporation
  • 16. GE HealthCare
  • 17. Kimal PLC
  • 18. Koninklijke Philips N.V.
  • 19. Lepu Medical Technology (Beijing) Co., Ltd.
  • 20. Medtronic PLC
  • 21. Merit Medical Systems, Inc.
  • 22. Nipro Corporation
  • 23. Penumbra, Inc.
  • 24. Sahajanand Medical Technologies Limited
  • 25. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • 26. Siemens Healthineers AG
  • 27. Summa Therapeutics, LLC
  • 28. Teleflex Incorporated
  • 29. Terumo Corporation
  • 30. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. PERIPHERAL VASCULAR DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. PERIPHERAL VASCULAR DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. PERIPHERAL VASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERIPHERAL VASCULAR DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 128. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 129. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 144. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 145. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 146. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 161. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 162. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 163. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 165. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 198. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 202. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 208. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 214. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 215. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 216. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 218. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 219. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 225. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 226. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 227. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 231. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 232. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 233. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 235. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 236. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 242. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 243. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 244. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 245. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 248. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 249. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 250. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 252. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 253. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 257. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 259. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 260. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 261. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 262. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 265. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 266. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 267. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 269. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 270. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 275. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 276. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 277. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 278. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 279. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 282. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 283. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 284. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 286. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 287. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 289. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 291. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 292. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 293. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 294. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 295. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
  • TABLE 296. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 300. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
  • TABLE 304. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 308. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
  • TABLE 310. PHILIPPINES PERIPHERAL VASCULAR DEVI